openPR Logo
Press release

Bilcare nCiD Technology receives 2014 Frost & Sullivan India Technology Innovation Award

10-10-2014 06:47 PM CET | Health & Medicine

Press release from: Bilcaretech

Bilcare nCiD Technology receives 2014 Frost & Sullivan India Technology Innovation Award

Mumbai, October 10, 2014: Bilcare nonClonable ID ™ Technology was conferred with prestigious Growth, Innovation & Leadership award 2014 by Frost & Sullivan, India. This award is conferred to recognize and reward innovation, technology and leadership best practice adopted by marquee companies across sectors. The function was attended by distinguished guests comprising innovators and visionary leaders from Corporate India.

Speaking on the occasion, Dr. Praful Naik, Ex. Director Bilcare Ltd. said: When the world was busy in creating clones of both living and non living , Bilcare gave birth to nonClonable ID™ Technology which today is finding applications in addressing counterfeiting in diverse industrial and governance sectors, including life saving medicines; endorsement from Frost & Sullivan is testimony to potential value that nCiD™ Technology can add across sectors for secured identity, authentication and track and trace of products and people in real time and adherence of e governance in various Government projects”.

Frost & Sullivan convened it's 2014 annual Growth, Innovation and Leadership Executive Congress (GIL 2014: India) at the Taj Hotel in Mumbai. This year's congress theme and focus was on recognizing emerging innovative and disruptive technologies that are radically disrupting, collapsing and transforming industries.

Frost & Sullivan's GIL Global Community continues to be the only resource in the world which supports CEOs and members of their management team with real world proven insights, tools, and strategies across more than twenty-four countries, forty-two industry verticals and market sectors and nearly one million executives around the globe.

About Bilcare Technology:
Bilcare Technologies is a research and technology leader focused on creating next-generation anti-counterfeiting solutions. Developed with breakthrough research in nanotechnology, Bilcare’s nonClonable ID™ enables products to be authenticated as they move through the supply chain to the end consumer across varied sectors. Bilcare is firmly committed to helping its clients accomplish their business goals, whilst protecting their brands against counterfeiting

Bilcare Technologies is a research and technology leader focused on creating next-generation anti-counterfeiting solutions.

1&2 floor, Mangalam House,
W H Road, Mumbai 400001

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bilcare nCiD Technology receives 2014 Frost & Sullivan India Technology Innovation Award here

News-ID: 297132 • Views:

More Releases from Bilcaretech

Bilcare Technologies launches nonClonable™ patient safety system in the US to …
24th February 2010, Miami, Florida: To protect against the increasing threat of counterfeiting, Bilcare Technologies announced today that it has launched its innovative nonClonable™ patient safety system in the US market. Taking a holistic approach to ensure the authenticity of medicines and help patients comply with medical prescriptions, the nonClonable™ system secures the supply chain and provides validation to various stakeholders including the patient. Bilcare Technologies unveiled nonClonable™ to the

More Releases for Bilcare

Clinical Trial Market may zoom in the Cloud | Myoderm, Bilcare, CliniChain
Global Clinical Trial Market Report, Production, Consumption and Forecast 2015-2026 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Clinical Trial Market. Some of the key players profiled in the study are Fisher Clinical
Healthcare Packaging Market Report for Period 2018 till 2024 Berry Plastics, Bil …
Global Healthcare Packaging market report emphasizes on detailed analysis of companies and manufacturers like Alcan Packaging, Aldelphi Healthcare Packaging, American Packaging Corporation, AMGRAPH Packaging, Ball Plastics Packaging, Beacon Converters, Cato Software Solutions, Amcor, Gerresheimer, Schott, Becton & Dickinson, Berry Plastics, Bilcare, CareFusion Corporation, Catalent and Others. This market study includes data about global market statistics, market share, company performances, historical analysis 2012 to 2016, market forecast 2017 to 2023 in
Global Pharmaceuticals Packaging Market 2017 : Schott, DuPont, West-P, Bilcare, …
Market Research Explore : The report 2017 Global Pharmaceuticals Packaging Market mainly highlights thoughtful facts and intelligence of Pharmaceuticals Packaging market in conjunction with prevailing and future market trends throughout the forecast period from 2017 to 2022. It additionally executes the great study of price, current geographical zones, technology, demand-supply and therefore the consequences it might wear the market growth of Pharmaceuticals Packaging trade. Do Enquiry concerning this analysis Report :
Electric Motor Market 2017 - Gerresheimer, Schott, DuPont, West-P, Bilcare, Nipr …
A market study based on the "Electric Motor Market" across the globe, recently added to the repository of Market Research, is titled ‘Global Electric Motor Market 2017’. The research report analyses the historical as well as present performance of the worldwide Electric Motor industry, and makes predictions on the future status of Electric Motor market on the basis of this analysis. Get Free Sample Copy of Report Here
Bilcare bags coveted the 2009 European Outsourcing award second time in successi …
Bilcare Ltd., service provider to the pharmaceutical companies spanning across their value chain from drug discovery to market bags the prestigious 2009 European Outsourcing Award for second time in succession. The award was bestowed at a gala dinner function in Madrid on October 16th, 2009 at the annual pharmaceutical flagship event, CPhI Worldwide, 2009. Dr. Praful Naik , Chief Scientific Officer and Executive Director, Bilcare Ltd accepted this prestigious award
Bilcare Global Clinical Supplies Appoints Vito Mangiardi as New CEO
PUNE, INDIA--(Marketwire - February 26, 2008) - Bilcare Global Clinical Supplies, [BilcareGCS.com] the single source provider of quality clinical trial materials from formulation and analytical services to IVRS and global distribution spread across the Americas, Europe and Asia, has appointed Vito Mangiardi, a 30-year Industry veteran as the new CEO to lead the firm. Speaking on this momentous occasion, Mr. Mohan Bhandari, Chairman & Managing Director, Bilcare Ltd., said, "Vito is